Cardiovascular systemic lupus erythematosus

Systemic Lupus Erythematosus, Fourth Edition

Volumn , Issue , 2004, Pages 913-942

  Petri, Michelle ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904029192     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012433901-9/50034-X     Document Type: Chapter

References (319)

1. M. Kaposi (1872) Neue beiträge zur kenntnis des lupus erythematosus. Arch. Dermat. U. Syph. 4 36.
2. E. Libman and B. Sacks (1924) A hitherto undescribed form of valvular and mural endocarditis. Arch. Intern. Med. 33 701-737.
3. M. Petri, M. Genovese, E. Engle and M. Hochberg (1991) Definition, incidence and clinical description of flare in systemic lupus erythematosus: A prospective cohort study. Arthritis Rheum. 34 937-944.
4. W. Brigden, E.G.L. Bywaters, M.H. Lessof and I.P. Ross (1960) The heart in systemic lupus erythematosus. Br. Heart J. 22 1-16.
5. M. Shearn (1959) The heart in systemic lupus erythematosus. Am. Heart J. 58 452-466.
6. P. Godeau, L. Guilleven, J. Fechner, G. Herreman and B. Wechsler (1981) Manifestations cardiques du lupus erythemateaux aigu dissemine. Nouv. Presse Med. 10 2175-2178.
7. A.D. Marks (1972) The cardiovascular manifestations of systemic lupus erythematosus. Am. J. Med. Sci. 264 254-265.
8. W.-H. Leung, K.-L. Wong, C.-P. Lau, C.-K. Wong and C.-H. Cheng (1990) Cardiac abnormalities in systemic lupus erythematosus: A prospective M-mode, cross-sectional and Doppler echocardiographic study. Int. J. Cardiol. 27 367-375.
9. R. Cervera, J. Font, C. Paré, M. Azqueta, F. Pérez-Villa, A. López-Soto, et al. (1992) Cardiac disease in systemic lupus erythematosus: Prospective study of 70 patients. Ann. Rheum. Dis. 51 156-159.
10. W.H. Leung, C.P. Lau, C.K. Wong and C.Y. Leung (1990) Fatal cardiac tamponade in systemic lupus erythematosus: A hazard of anti-coagulation. Am. Heart. J. 119 422-423.
11. E.J. Jacobson and M.J. Reza (1978) Constrictive pericarditis in systemic lupus erythematosus. Arthritis Rheum. 21 972-974.
12. M.R. Hejtmancik, J.C. Wright and R. Quint (1964) The cardiovascular manifestations of systemic lupus erythematosus. Am. Heart J. 68 119-130.
13. P.M. Yurchak, S.A. Levine and R. Gorlin (1965) Contrictive pericarditis complicating disseminated lupus erythematosus. Circulation 31 113-118.
14. R.H. Starkey and B.H. Hahn (1973) Rapid development of constrictive pericarditis in a patient with systemic lupus erythematosus. Chest 63 448-450.
15. B.L. Chia, E.P. Mah and P.H. Feng (1981) Cardiovascular abnormalities in systemic lupus erythematosus. J. Clin. Ultrasound 9 237-243.
16. B.S. Maniscalco, J.M. Felner, J.L. McCans and J.A. Chiapella (1975) Echocardiographic abnormalities in systemic lupus erythematosus [abstract]. Circulation 52(Suppl. II), II-211.
17. I. Schnittger, R. Bowden, J. Abrams and R.L. Popp (1978) Echocardiography: Pericardial thickening and constrictive pericarditis. Am. J. Cardiol. 42 388-395.
18. H. Feigenbaum (1972) Echocardiography Philadelphia: Lea & Febiger
19. P. Nihoyannopoulos, P.M. Gomez, J. Joshi, S. Loizou, M.J. Walport and C.M. Oakley (1990) Cardiac abnormalities in systemic lupus erythematosus: Assocition with raised anticardiolipin antibodies. Circulation 82 369-375.
20. R. Armas-Cruz, J. Harnecker, G. Ducach, J. Jalil and F. Gonzales (1958) Clinical diagnosis of systemic lupus erythematosus. Am. J. Med. 25 409-419.
21. G.D. Copeland, D. von Capeller and T.N. Stern (1958) Systemic lupus erythematosus: A clinical report of fortyseven cases with pathologic findings in eighteen. Am. J. Med. Sci. 236 318-326.
22. G.C. Griffith and I.L. Vural (1951) Acute and subacute disseminated lupus erythematosus: A correlation of clinical and postmortem findings in eighteen cases. Circulation 3 492.
23. L. Gross (1940) The cardial lesions in Libman-Sacks disease with a consideration of its relationship to acute diffuse lupus erythematosus. Am. J. Pathol. 16 375-407.
24. A.M. Harvey, L.E. Shulman, P.A. Tumulty, C.L. Conley and E.H. Schoenrich (1954) Systemic lupus erythematosus: Review of the literature and clinical analysis of 138 cases. Medicine 33 291-437.
25. E. Humphreys (1948) The cardiac lesions of acute disseminated lupus erythematosus. Ann. Intern. Med. 28 12-14.
26. R.A. Jessar, W. Lamont-Havers and C. Ragan (1953) Natural history of lupus erythematosus disseminatus. Ann. Intern. Med. 38 717-731.
27. B.H. Bulkley and W.C. Roberts (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: A study of 36 necropsy patients. Am. J. Med. 58 243-264.
28. R. Collins, R.A. Turner, M. Nomeir, et al. (1978) Cardiopulmonary manifestations of systemic lupus erythematosus. J. Rheumatol. 5 299-306.
29. D. Estes and C.L. Christian (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine 50 85-95.
30. E.L. Dubois (1976) 2nd ed Lupus Erythematosus: A Review of the Current Status of Discoid and Systemic Lupus Erythematosus and Their Varients Los Angeles: Univ. of Southern California Press
31. E.L. Dubois and D.L. Tuffanelli (1964) Clinical manifestations of systemic lupus erythematosus. J. Am. Med. Assoc. 190 104-111.
32. U. Elkayam, S. Weiss and S. Laniado (1977) Pericardial effusion and mitral valve involvement in systemic lupus erythematosus: Echocardiographic study. Ann. Rheum. Dis. 36 349-353.
33. M. Ito, Y. Kagiyama, I. Omura, Y. Hiramatsu, E. Kurata, S. Kanaya, et al. (1979) Cardiovascular manifestations in systemic lupus erythematosus. Jpn. Circ. J. 43 985-994.
34. T.N. James, C.E. Rupe and R.W. Monto (1965) Pathology of the cardiac conduction system in systemic lupus erythematosus. Ann. Intern. Med. 63 402-410.
35. T.Q. Kong, R.E. Kellum and J.R. Haserick (1962) Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: A correlation of clinical and autopsy findings in thirty patients. Circulation 26 7-11.
36. M.W. Ropes (1976) Systemic Lupus Erythematosus Cambridge, Massachusetts: Harvard Univ. Press
37. E. Badui, D. Garcia-Rubi, E. Robles, J. Jimenez, L. Juan, M. Deleze, et al. (1985) Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 36 431-441.
38. A.K. Bidani, J.L. Roberts, M.M. Schwartz and E.J. Lewis (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am. J. Med. 69 849-858.
39. J.S. Bomalaski, J.V. Talano and S. Perlman (1983) The value of echocardiography in patients with systemic lupus erythematosus [abstract]. Clin. Res. 31 68.
40. I.G. Crozier, E. Li, M.J. Milne and M.G. Nicholls (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am. J. Cardiol. 65 1145-1148.
41. N.E. Doherty III, G. Feldman, G. Maurer and R.J. Siegel (1988) Echocardiographic findings in systemic lupus erythematosus. Am. J. Cardiol. 61 1144.
42. A.V. Klinkhoff, C.R. Thompson, G.D. Reid and C.W. Tomlinson (1985) M-mode and two dimensional echocardiographic abnormalities in systemic lupus erythematosus. J. Am. Med. Assoc. 253 3273-3277.
43. M. Pistiner, D.J. Wallace, S. Nessim, A.L. Metzger and J.R. Klinenberg (1991) Lupus erythematosus in the 1980s: A survey of 570 patients. Semin. Arthritis Rheum. 21 55-64.
44. G. Sturfelt, J. Eskilsson, O. Nived, L. Truedsson and S. Valind (1992) Cardiovascular disease in systemic lupus erythematosus: A study of 75 patients from a defined population. Medicine 71 216-223.
45. B.F. Mandell (1987) Cardiovascular involvement in systemic lupus erythematosus. Semin. Arthritis Rheum. 17 126-141.
46. N.E. Doherty and R.J. Siegel (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am. Heart J. 110 1257-1265.
47. G.G. Hunder, B.J. Mullen and F.C. McDuffie (1974) Complement in pericardial fluid of lupus erythematosus. Ann. Intern. Med. 80 453-458.
48. C. Tamburino, C.E. Fiore, R. Foti, E. Salomone, R. Di Paola and D.R. Grimaldi (1989) Endomyocardial biopsys in diagnosis and management of cardiovascular maniestations of systemic lupus erythematosus (SLE). Clin. Rheumatol. 8 108-112.
49. A. Herskowitz, S. Campbell, J. Deckers, E.K. Kasper, J. Boehmer, D. Hadian, et al. (1993) Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsys. Am. J. Cardiol. 71 982-986.
50. D.L. Larson (1961) Systemic Lupus Erythematosus Boston: Little, Brown & Co.
51. D.G. Borenstein, W.B. Fye, F.C. Arnett and M.B. Stevens (1978) The myocarditis of systemic lupus erythematosus: Association with myositis. Ann. Intern. Med. 89 619-624.
52. G. Berg, J. Bodet, K. Webb, G. Williams, D. Palmer, B. Ruoff, et al. (1985) Systemic lupus erythematosus presenting as isolated congestive heart failure. J. Rheumatol. 12 1182-1185.
53. M. Been, B.J. Thomson, M.A. Smith, J.P. Ridgway, R.H.B. Douglas, M. Been, et al. (1988) Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. Eur. Heart J. 9 1250-1256.
54. T. Takahashi, T. Suzuki, A. Suzuki, T. Yamada, N. Koido, S. Akizuki, et al. (1999) A case of systemic lupus erythematosus with interstitial myocarditis leading to sudden death. Ryumachi 39 573-579.
55. N. Simon, H. Cohen, G. Glick, A. Kanter, B. Levin and C.L. Pirani (1973) Clinical pathologic conference. Am. Heart J. 86 539-552.
56. M.J. Fairfax, T.G. Osborn, G.A. Williams, C.C. Tsai and T.L. Moore (1988) Endomyocardial biopsy in patients with systemic lupus erythematosus. J. Rheumatol. 15 593-596.
57. K. Enomoto, Y. Kaji, T. Mayumi, Y. Tsuda, S. Kanaya, K. Nagasawa, et al. (1991) Left ventricular function in patients with stable systemic lupus erythematosus. Jpn. Heat J. 32 445-453.
58. K. Murai, H. Oku, K. Takeuchi, Y. Kanayama, T. Inoue and T. Takeda (1987) Alterations in myocardial systolic and diastolic function in patients with active systemic lupus erythematosus. Am. Heart J. 113 966-971.
59. V.K. Bahl, S. Aradhye, R.S. Vasan, A/ Malhotra, K.S. Reddy and A.N. Malaviya (1992) Myocardial systolic function in systemic lupus erythematosus: A study based on radionuclide ventriculography. Clin. Cardiol. 15 433-435.
60. J.D. Hospenpud, A. Montanaro, M.V. Hart, J.E. Haines, H.D. Specht, R.M. Bennett, et al. (1984) Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am. J. Med. 77 286-292.
61. A. Giunta, U. Picillo, S. Maione, S. Migliaresi, G. Valentini, M. Arnese, et al. (1993) Spectrum of cardiac involvement in systemic lupus erythematosus: Echocardiographic, echo-doppler observations and immunological investigation. Acta Cardiol. 48 183-197.
62. C.A. Roldan, B.K. Shively, C.C. Lau, F.T. Gurule, E.A. Smith and M.H. Crawford (1992) Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J. Am. Coll. Cardiol. 20 1127-1134.
63. T.M. Winslow, M.A. Ossipov, G.P. Fazio, E. Foster, J.S. Simonson and N.B. Schiller (1993) The left ventricle in systemic lupus erythematosus: Initial observations and a five-year follow-up in a university medical center population. Am. Heart J. 125 1117-1122.
64. B.E. Strauer, I. Brune, H. Schenk, D. Knoll and E. Perings (1976) Lupus cardiomyopathy: Cardiac mechanics, hemodynamics, and coronary blood flow in uncomplicated systemic lupus erythematosus. Am. Heart J. 92 715-722.
65. A. Rangel, M. Basave, C. Lavalle, L. Hermandez, J. Ochoa, E. Chavez, et al. (2000) Endomyocardial fibrosis (Davies disease) coincidental with systemic lupus erythematosus. Arch. Inst. Cardiol. Mex. 70 66-71.
66. M. Hartford, J. Wikstrand, I. Wallentin, S. Ljungman, L. Wilhelmsen and G. Berglund (1984) Diastolic function of the heart in untreated primary hypertension. Hypertension 6 329.
67. K. Ueno, S. Fujimoto, T. Fujimoto, H. Nakano, T. Nakajima, S. Yamano, et al. (1999) A case of systemic lupus erythematosus discovered from left heart failure due to lupus induced mitral regurgitation. Ryumachi 39 778-783.
68. P. Klemperer (1950) The concept of collagen diseases. Am. J. Pathol. 26 505-519.
69. G.W. Daugherty and A.H. Baggenstoss (1950) Syndrome characterized by glomerulonephritis and arthritis. Libman-Sacks disease with predominantly renal involvement. Arch. Intern. Med. 85 900-923.
70. K.V. Straaton, W.W. Chatham, J.D. Reveille, W.J. Koopman and S.H. Smith (1988) Clinically significant valvular heart disease in systemic lupus erythematosus. Am. J. Med. 85 645-650.
71. E. Galve, J. Candell-Riera, C.P.-M.G. Pigrau C. aiPermanyer-Miralda^G., H. Garcia-Del-Castillo and J. Soler-Soler (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N. Engl. J. Med. 319 817-823.
72. M.A. Khamashta, R. Cervera, R.A. Asherson, J. Font, A. Gil, D.J. Coltart, et al. (1990) Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 335 1541-1544.
73. C.B. Gleason, M.E. Stoddard, S.G. Wagner, R.A. Longaker, S. Pierageli and E.N. Harris (1993) A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am. Heart J. 125 1123-1129.
74. D. Metz, D. Jolly, J. Graciet-Richard, J.L. Pennaforte, P. Nazeyrollas, J.P. Chabert, et al. (1994) Prevalence of valvular involvement in systemic lupus erythematosus and association with antiphospholipid syndrome: A matched echocardiographic study. Cardiology 85 129-136.
75. O. Meyer, M. Golstein, P. Nicaise, C. Labarre and M.F. Kahn (1995) Heart of valve disease in systemic lupus erythematosus: Role of antiphospholipid antibodies. Clin. Rev. Allergy Immunol. 13 49-56.
76. F. Gabrielli, E. Alcini, M.A. Di Prima, G. Mazzacurati and C. Masala (1995) Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: Lack of correlation with antiphospholipid antibodies. Int. J. Cardiol. 51 117-126.
77. S. Rantapaa-Dahlqvist, G. Neumann-Andersen, C. Backman, G. Dahlen and B. Stegmayr (1997) Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus. Clin. Rheumatol. 16 140-148.
78. R.F. Shapiro, C.N. Gamble, K.B. Wiesner, J.J. Castles, A.W. Wolf, E.J. Hurley, et al. (1977) Immunopathogenesis of Libman-Sacks endocarditis: Assessment by light and immunofluorescent microscopy in two patients. Ann. Rheum. Dis. 36 508-516.
79. C.A. Roldan, B.K. Shively and M.H. Crawford (1996) An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N. Engl. J. Med. 335 1424-1430.
80. G. Nesher, J. Ilany, D. Rosenmann and A.S. Abraham (1997) Valvular dysfunction in antiphospholipid syndrome: Prevalence, clinical features, and treatment. Semin. Arthritis Rheum. 27 27-35.
81. J.L. Vianna, M.A. Khamashta, J. Ordi-Ros, F. Font, R. Cervera, A. Lopez-Soto, et al. (1994) Comparison of the primary and secondary antiphospholipid syndrome: A European multicenter study of 114 patients. Am. J. Med. 96 3-9.
82. E. Galve, J. Ordi, J. Barquinero, A. Evangelista, M. Vilardell and J. Soler-Soler (1992) Valvular heart disease in the primary antiphospholipid syndrome. Ann. Intern. Med. 116 293-298.
83. B. Brenner, Z. Blumenfeld, W. Markiewicz and S.A. Reisner (1991) Cardiac involvement in patients with primary anti-phospholipid syndrome. J. Am. Coll. Cardiol. 18 931-936.
84. R. Garcia-Torres, M.C. Amigo, A. de la Rossa, A. Moron and P.A. Reyes (1996) Valvular heart disease in primary antiphospholipid syndrome: Clinical and morphological findings. Lupus 5 56-61.
85. E. Badui, S. Solorio, E. Martinez, G. Bravo, R. Enciso, L. Barile, et al. (1995) The heart in the primary antiphospholipid syndrome. Arch. Med. Res. 26 115-120.
86. R. Cervera, M.A. Khamashta, J. Font, P.A. Reyes, J.L. Vianna, A. Lopez-Soto, et al. (1991) High prevalence of significant heart valve lesions in patients with the primary antiphospholipid syndrome. Lupus 1 43-47.
87. P.H. Ford, S.E. Ford and D.P. Lillicrap (1988) Association of lupus anticoagulant with severe valvular heart disease in SLE. J. Rheumatol. 15 597-600.
88. E.K. Chartash, D.M. Lans, S.A. Paget, T. Qamar and M.D. Lockshin (1989) Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am. J. Med. 86 407-412.
89. W.-H. Leung, K.-L. Wong, C.-P. Lau, C.-L. Wong and H.-W. Liu (1990) Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am. J. Med. 89 411-419.
90. E.K. Li, I.G. Crozier, M.J. Milne, M.G. Nicholls and M.G. Cohen (1990) Lack of association between anticardiolipin antibodies and heart valve disease in Chinese patients with systemic lupus erythematosus [letter]. Lancet 336 504-505.
91. M.L. Ong, K. Veerapen, J.B. Chambers, M.N. Lim, M. Manivasagar and F. Wang (1992) Cardiac abnor malities in systemic lupus erythematosus: Prevalence and relationship to disease activity. Int. J. Cardiol. 34 69-74.
92. R. Ramonda, A. Doria, C. Villanova, E. Vaccaro, L. Punzi, G. Fasoli, et al. (1992) Evaluation de l'atteinte cardiaque au cours du lupus erythemateux disseminé: Étude clinique et échocardiographque. Rev. Rheum. Mal Osteoartic. 59 790-796.
93. C. Lolli, M. Foscoli, R. Giofré, S.P. Tarquini and G.P. Toschi (1993) Anomalie cardiache nel Lupus Eritematoso Sistemico: Prevalenza e relazione con durata, attivitá della malattia e presenza di anticorpi antifosfolipidi. G. Ital. Cardiol. 23 1125-1134.
94. B. Laganá (1993) Anormalitá cardiache in corso di lupus eritematoso sistemico e loro associazione con gli anticropi antifosfolipidi. Rec. Progr. Med. 84 662-672.
95. L. Ziporen, I. Goldberg, M. Arad, M. Hojnik, J. Ordi-Ros, A. Afek, et al. (1996) Libman-Sacks endocarditis in the antiphospholipid syndrome: Immunopathologic findings in deformed heart valves. Lupus 5 196-205.
96. H.M. Connolly, J.L. Crary, M.D. McGoon, D.D. Hensrud, B.S. Edwards, W.D. Edwards, et al. (1997) Valvular heart disease associated with fenfluramine-phentermine. N. Engl. J. Med. 337 581-588.
97. D.J. Graham and L. Green (1997) Further cases of valvular heart disease associated with flenfluramine-phentermine. N. Engl. J. Med. 337 635.
98. L. Cannistra (1997) Valvular heart disease associated with dexfenfluramine. N. Engl. J. Med. 337 636.
99. J.P. Buyon, R.J. Winchester, S.G. Slade, F. Arnett, J. Copel, D. Friedman, et al. (1993) Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La. Arthritis Rheum. 36 1263-1273.
100. M. Petri, R. Watson and M.C. Hochberg (1989) Anti-Ro antibodies and neonatal lupus. Rheum. Dis. Clin. North Am. 15 335-360.
101. G. Ferrazzini, M. Fasnacht, U. Arbenz, R. Seger, R. Biedermann, B. Simma, et al. (1996) Neonatal lupus erythematosus with congenital heart block and severe heart failure due to myocarditis and endocarditis of the mitral valve. Intensive Care Med. 22 464-466.
102. E. Taylor-Albert, M. Reichlin, W.H. Toews, E.D. Overholt and L.A. Lee (1997) Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: Case reports, autoantibody analysis, and management. Pediatrics 99 733-735.
103. T. Okada and Y. Shiokawa (1975) Cardiac lesions in collagen disease. Jpn. Circ. J. 39 479-484.
104. A. del Rio, J.J. Vázquez, J.A. Sobrino, A. Gil, J. Barbado, I. Maté, et al. (1978) Myocardial involvement in systemic lupus erythematosus: A noninvasive study of left ventricular function. Chest 74 414-417.
105. D. Mevorach, E. Raz, O. Shalev, I. Steiner and E. Ben-Chetrit (1993) Complete heart block and seizures in an adult with systemic lupus erythematosus: A possible pathophysiologic role for anti-SS-A/Ro and Anti-SS-B/La autoantibodies. Arthritis Rheum. 36 259-262.
106. X. Martinez-Costa, J. Ordi, J. Barberá, A. Selva, J. Bosch and M. Vilardell (1991) High grade atrioventricular heart block in 2 adults with systemic lupus erythematosus. J. Rheumatol. 18 1926-1928.
107. S. Bharati, D.J. de la Fuente, R.J. Kallen, Y. Freij and M. Lev (1975) Conduction system in systemic lupus erythematosus with atrioventricular block. Am. J. Cardiol. 35 299-304.
108. J. Guzman, M.H. Cardiel, A. Arce-Salinas and D. Alarcon-Segovia (1994) The contribution of resting heart rate and routine blood tests to the clinical assessment of disease activity in systemic lupus erythematosus. J. Rheumatol. 21 1845-1848.
109. C.J. Homcy, R.R. Liberthson, J.T. Fallon, S. Gross and L.M. Miller (1982) Ischemic heart disease in systemic lupus erythematosus in the young patient: Report of 6 cases. Am. J. Cardiol. 49 478-484.
110. T.A. Bonfiglio, R.E. Botti and J.W.C. Hagstrom (1972) Coronary arteritis, occlusion and myocardial infarction due to lupus erythematosus. Am. Heart J. 83 153-158.
111. V.E. Wilson, S.L. Eck and E.R. Bates (1992) Evaluation and treatment of acute myocardial infarction complicating systemic lupus erythematosus. Chest 101 420-424.
112. I. Bor (1968) Cardiac infarction in the Libman-Sacks endocarditis [letter]. N. Engl. J. Med. 279 164.
113. N. Ohara, T. Miyata, A. Kurata, H. Oshiro, O. Sato and H. Shigematsu (2000) Ten years' experience of aortic aneurysm associated with systemic lupus erythematosus. Eur. J. Vasc. Endovasc. Surg. 19 288-293.
114. R.H. Heibel, J.D. O'Toole, E.I. Curtiss, T.A. Medsger Jr., S.P. Reddy and J.A. Shaver (1976) Coronary arteritis in systemic lupus erythematosus. Chest 69 200-203.
115. Y. Takatsu, R. Hattori, K. Sakaguchi, Y. Yui and C. Kawai (1985) Acute myocardial infarction associated with systemic lupus erythematosus documented by coronary arteriograms. Chest 88 147-149.
116. D.J. Wallace and E.L. Dubois (1987) 3rd ed Dubois' Lupus Erythematosus Lhiladelphia: Lea & Febiger
117. E.C. Keat and J.H. Shore (1958) Gangrene of the legs in disseminated lupus erythematosus. Br. Med. J. 5061 2527-2531.
118. S.M. Korbet, M.M. Schwartz and E.J. Lewis (1984) Immune complex deposition and coronary vasculitis in systemic lupus erythematosus. Am. J. Med. 77 141-146.
119. H. Kurokawa, T. Kondo, Y. Shiga, M. Nomura, Y. Mizuno, M. Ashiwara, et al. (1986) Myocardial infarction due to thrombi in coronary aneurysms in a young women with systemic lupus erythematosus. J. Cardiogr. 16 249-258.
120. B.M. Benisch and N. Pervez (1974) Coronary artery vasculitis and myocardial infarction with systemic lupus erythematosus. N. Y. State J. Med. 74 873-874.
121. B. Castleman and V.P. Dole (1962) Case records of the Massachusetts General Hospital: Case 1—1962. N. Engl. J. Med. 266 42-49.
122. J.A. Englund and R.U. Lucas (1983) Cardiac complications in children with systemic lupus erythematosus. Pediatrics 72 724-730.
123. T. Uchida, T. Inoue, H. Kamishirado, T. Nakata, Y. Sakai, K. Takayanagi, et al. (2001) Unusual coronary artery aneurysm and acute myocardial infarction in a middle-aged man with systemic lupus erythematosus. Am. J. Med. Sci. 322 163-165.
124. J.S. Simonson, N.B. Schiller, M. Petri and D.B. Hellmann (1989) Pulmonary hypertension in systemic lupus erythematosus. J. Rheumatol. 16 918-925.
125. T.M. Winslow, M.A. Ossipov, G.P. Fazio, J.S. Simonson, R.F. Redberg and N.B. Schiller (1995) Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am. Heart J. 129 510-515.
126. H.D. Perez and N. Kramer (1981) Pulmonary hypertension in systemic lupus erythematosus: Report of four cases and review of the literature. Semin. Arthritis Rheum. 11 177-181.
127. F.P. Quismorio Jr., O. Sharma, M. Koss, T. Boylen, A.W. Edmiston, P.J. Thornton, et al. (1984) Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin. Arthritis Rheum. 13 349-359.
128. R.A. Asherson, D. Hackett, A.E. Gharavi, E.N. Harris, H.G. Kennedy and G.R.V. Hughes (1986) Pulmonary hypertension in systemic lupus erythematosus: A report of three cases. J. Rheumatol. 13 416-420.
129. K. Wakaki, F. Koizumi and M. Fukase (1984) Vascular lesions in systemic lupus erythematosus (SLE) with pulmonary hypertension. Acta Pathol. Jpn. 34 593-604.
130. C.A. Wagenvoort and N. Wagenvoort (1970) Primary pulmonary hypertension: A pathologic study of the vessels in 156 clinically diagnosed cases. Circulation 42 1163-1184.
131. G. Walcott, H.B. Burchell and A.L. Brown (1970) Primary pulmonary hypertension. Am. J. Med. 49 70-79.
132. S. Kuramochi, Y. Tashiro, C. Torikata and Y. Watanabe (1982) Systemic lupus erythematosus associated with multiple nodular hyperplasia of the liver. Acta Pathol. Jpn. 32 547-560.
133. D.E. Furst, J.A. Davis, P.J. Clements, S.K. Chopra, A.N. Theofilopoulos and D. Chia (1981) Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. Arthritis Rheum. 24 1403-1408.
134. A. Rozkovec, R. Bernstein, R.A. Asherson and C.M. Oakley (1983) Vascular reactivity and pulmonary hypertension in systemic sclerosis. Arthritis Rheum. 26 1037-1040.
135. R.A. Asherson and C.M. Oakley (1986) Pulmonary hypertension and systemic lupus erythematosus [editorial]. J. Rheumatol. 13 1-5.
136. J. de la Mata, M.A. Gomez-Sanchez, M. Aranzana and J.J. Gomez-Reino (1994) Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases. Arthritis Rheum. 37 1528-1533.
137. L.J. Rubin, D.B. Badesch, R.J. Barst, N. Galie, C.M. Black, A. Keogh, et al. (2000) Bosentan therapy for pulmonary arterial hypertension. N. Engl. J. Med. 346 896-903.
138. L.J. Rubin (1997) Primary pulmonary hypertension. N. Engl. J. Med. 336 111-117.
139. H.P. Gurtner (1985) A minorex and pulmonary hypertension. Cor Vasa 27 160-171.
140. L. Abenhaim, Y. Moride, F. Brenot, et al. (1996) Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N. Engl. J. Med. 335 609-616.
141. G.D. Curfman (1997) Diet pills redux [editorial]. N. Engl. J. Med. 337 629-630.
142. E.J. Mark, E.D. Patalas, H.T. Chang, R.J. Evans and S.C. Kessler (1997) Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N. Engl. J. Med. 337 602-606.
143. E.K. Weir, H.L. Reeve, J.M. Huang, et al. (1996) Anorexic drugs aminorex, fenfluramine, and dexfen-fluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasocon-striction. Circulation 94 2216-2220.
144. D.R. Budman and A.D. Steinberg (1976) Hypertension and renal disease in systemic lupus erythematosus. Arch. Intern. Med. 136 1003-1007.
145. A. Schieppati and G. Remuzzi (1993) Hypertension in renal disease: Pathophysiological, functional, and clinical implications. Am. J. Kidney Dis. 21 58-60.
146. V.E. Pollack and K.S. Kant (1991) Diffuse and focal proliferative lupus nephritis: Treatment approaches and results. Nephron 59 177-183.
147. L.J. Sofer and R. Bader (1952) Corticotropin and cortisone in acute disseminated lupus erythematosus. J. Am. Med. Assoc. 149 1002-1008.
148. E.L. Dubois, R.R. Commons, P. Starr, C.S. Stein Jr. and R. Morrison (1952) Corticotropin and cortisone treatment for systemic lupus erythematosus. J. Am. Med. Assoc. 149 995.
149. D. Kaplan, E.M. Ginzler and J. Feldman (1992) Arthritis and hypertension in patients with systemic lupus erythematosus. Arthritis Rheum. 35 423-428.
150. M. Petri, C. Lakatta, L. Magder and D.W. Goldman (1994) Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis. Am. J. Med. 96 254-259.
151. M. Petri, S. Perez-Gutthann, D. Spence and M.C. Hochberg (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am. J. Med. 93 513-519.
152. M. Petri, S. Perez-Gutthann, J.C. Longenecker and M.C. Hochberg (1991) Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. am. J. Med. 91 345-353.
153. M. Petri (1997) Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North Am. 23 1-14.
154. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) [see comments]. Arch. Intern. Med. 153 154-183.
155. E.J. Lewis, L.G. Hunsicker, R.P. Bain and R.D. Rohde (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N. Engl. J. Med. 329 1456-1462.
156. B. Dahlof, R.B. Devereux, S.E. Kjeldsen, S. Julius, G. Beevers, U. de Faire, et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 359 995-1003.
157. J. Meller, C.A. Conde, L.M. Deppisch, E. Donoso and S. Dack (1975) Myocardial infarction due to coronary atherosclerosis in three young adults with systemic lupus erythematosus. Am. J. Cardiol. 35 309-314.
158. C. Aranow and E.M. Ginzler (2000) Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 9 166-169.
159. M.B. Urowitz and D.D. Gladman (1999) Evolving spectrum of mortality and morbidity in SLE [editorial]. Lupus 8 253-255.
160. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger Jr., L. Jansen-McWilliams, et al. (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am. J. Epidemiol. 145 408-415.
161. M.M. Ward (1999) Premature morbidity from cardiovascular and cerbrovascular disease in women with systemic lupus erythematosus. Arthritis Rheum. 42 338-346.
162. R.E. Patterson, S.F. Horowitz and R.L. Eisner (1994) Comparison of modalities to diagnose coronary artery disease. Semin. Nucl. Med. 24 286-310.
163. J. Grégoire and P. Théroux (1990) Detection and assessment of unstable angina using myocardial perfusion imaging: Comparison between technetium-99m sestamibi SPECT and 12-lead elecrocardiogram. Am. J. Cardiol. 66 44E-46E.
164. C. Manca, L. Dei Cas, D. Albertini, G. Baldi and O. Visioli (1978) Different prognostic value of exercise electrocardiogram in men and women. Cardiology 63 312-319.
165. A.G. Bartel (1979) Exercise stress testing—current status. Cardiology 64 170-189.
166. J.S. Borer, J.F. Brensike, D.R. Redwood, S.B. Itscoitz, E.R. Passamani, N.J. Stone, et al. (1975) Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N. Engl. J. Med. 293 367-371.
167. S. Manzi, F. Selzer, K. Sutton-Tyrrell, S.G. Fitzgerald, J.E. Rairie, R.P. Tracy, et al. (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 42 51-60.
168. M. Petri (2000) Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 9 170-175.
169. E. Svenungsson, K. Jensen-Urstad, M. Heimburger, A. Silveira, A. Hamsten, U. de Faire, et al. (2001) Risk factors for cardiovascular disease in systemic lupus erythe matosus. Circulation 104 1887-1893.
170. A.S. Iskandrian and J. Heo (1992) Thallium-201 myocardial imaging. J.H.C. Reiber, E.E. van der Wall (Eds) Cardiovascular Nuclear Medicine and MRI Amsterdam: Kluwer 223-238.
171. D.S. Berman, H. Kiat, K.F. van Train, J. Friedman, E.V. Garcia and J. Maddahi (1990) Comparison of SPECT using Technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am. J. Cardiol. 66 72E-79E.
172. J. Maddahi, H. Kiat, K.F. van Train, F. Prigent, J. Friedman, E.V. Garcia, et al. (1990) Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am. J. Cardiol. 66 55E-62E.
173. R. Taillefer (1990) Technetium-99m sestamibi myocardial imaging: Same-day rest-stress studies and dipyridamole. Am. J. Cardiol. 66 80E-84E.
174. I.N. Bruce, R.J. Burns, D.D. Gladman and M.B. Urowitz (2000) Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. I. Prevalence and distribution of abnormalities. J. Rheumatol. 27 2372-2377.
175. S.S. Sun, Y.C. Shiau, S.C. Tsai, C.C. Lin, A. Kao and C.C. Lee (2001) The role of technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erhthematosus patients with nonspecific chest complaints. Rheumatology (Oxford) 40 1106-1111.
176. L.E. Samoilenko, O.A. Fomicheva, E.L. Nasonov, A.N. Samko, A. Karpov Iu and V.B. Sergienko (2001) Myocardial microcirculation in patients with systemic lupus erythematosus. Ter. Arkh. 73 29-33.
177. F. Selzer, K. Sutton-Tyrrell, S.G. Fitzgerald, R. Tracy, L.H. Kuller and S. Manzi (2001) Vascular stiffness in women with systemic lupus erythematosus. Hypertension 37 1075-1082.
178. D.S. Lima, E.I. Sato, V.C. Lima, F. Miranda Jr. and F.H. Hatta (2002) Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J. Rheumatol. 29 292-297.
179. Y.S. Haider and W.C. Roberts (1981) Coronary arterial disease in systemic lupus erythematosus: Quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am. J. Med. 70 775-781.
180. M. Abu-Shakra, M.B. Urowitz, D.D. Gladman and J. Gough (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J. Rheumatol. 22 1259-1264.
181. L.A. Rubin, M.B. Urowitz and D.D. Gladman (1985) Mortality studies in systemic lupus erythematosis: The bimodal pattern revisited. Q. J. Med. 55 87-98.
182. G.P. Shome, M. Sakauchi, K. Yamane, H. Takemura and H. Kashiwagi (1989) Ischemic heart disease in systemic lupus erythematosus. A retrospective study of 65 patients treated with prednisone. Jpn. J. Med. 28 599-603.
183. M. Hearth-Holmes, B.A. Baethge, L. Broadwell and R.E. Wolf (1995) Dietary treatment of hyperlipidemia in patients with systemic lupus erythematosus. J. Rheumatol. 22 450-454.
184. M.B. Urowitz, A.A.M. Bookman, B.E. Koehler, D.A. Gordon, H.A. Smythe and M.A. Ogryzlo (1976) The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60 221-225.
185. D.D. Gladman and M.B. Urowitz (1987) Morbidity in systemic lupus erythematosus. J. Rheumatol. 14(Suppl. 13), 223-226.
186. H. Jonsson, O. Nived and G. Sturfelt (1989) Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine 68 141-150.
187. C.R. Minick and G.E. Murphy (1966) Experimental induction of atherosclerosis by the synergy of allergic injury to arteries and lipid rich diet. I Effect of repeated injections of mouse serum in rabbits fed a dietary cholesterol supplement. J. Exp. Med. 124 635-652.
188. C.R. Minick and G.E. Murphy (1973) Experimental induction of atherosclerosis by the synergy of allergic injury to arteries and lipid rich diet. II Effect of repeatedly injecting foreign protein in rabbits fed a lipid-rich cholesterol-poor diet. Am. J. Pathol. 73 265-300.
189. M.J. Hardin, C.R. Minick and G.E. Murphy (1973) Experimental induction of atherosclerosis by the synergy of allergic injury to arteries and lipid rich diet. III The role of earlier acquired fibro muscular intimal thickening in the pathogenesis of later developing arteriosclerosis. Am. J. Pathol. 73 301-327.
190. C.R. Minick, C.G. Fabricant, J. Fabricant and M.M. Litrenta (1979) A thero/arteriosclerosis induced by infection with a Herpes virus. Am. J. Pathol. 96 673-706.
191. R. Kliendienst, G. Schett, A. Amberger, et al. (1995) Atherosclerosis as an autoimmune condition. Isr. J. Med. Sci. 31 596-599.
192. L.M. Hang, S. Izui and F.J. Dixon (1981) (NZW × BXSB) F1 hybrid: A model of acute lupus and coronary vascular disease with myocardial infarction. J. Exp. Med. 154 216-221.
193. J.H.M. Berden, L.M. Hang, P.J. McConahey and F.J. Dixon (1983) Analysis of vascular lesions in murine SLE. I. Association with serological abnormalities. J. Immunol. 130 1699-1705.
194. L.M. Hang, P.M. Stephan-Larson, J.P. Henry and F.J. Dixon (1983) The role of hypertension in the vascular disease and myocardial infarcts associated with murine systemic lupus erythematosus. Arthritis Rheum. 26 1340-1345.
195. C.C. Hudgins, R.T. Steinberg, D.M. Klinman, M.J.P. Reeves and A.D. Steinberg (1985) Studies of consomic mice bearing the y chromosome of the BXSB mouse. J. Immunol. 134 3849-3854.
196. H. Yoshida, H. Fujiwara, T. Fujiwara, S. Ikehara and Y. Hamashema (1987) Quantitative analysis of myocardial infarction in NZW × BXSB F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. Am. J. Pathol. 129 477-485.
197. A.E. Kabakov, V.V. Tertov, V.A. Saenko, A.M. Poverenny and A.N. Orekhov (1992) The atherogenic effect of lupus sera: Systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta. Clin. Immunol. Immunopathol. 63 214-220.
198. S. Fukumoto, T. Tsumagari, M. Kinjo and K. Tanaka (1987) Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol. Jpn. 37 1-9.
199. R.A. Asherson, M.A. Khamashta, E. Baguley, C.M. Oakley, N.R. Rowell and G.R.V. Hughes (1989) Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q. J. Med. 73 1103-1115.
200. N. Kattwinkel, A.G. Villanueva, S.B. Labib, H.T. Aretz, J.W. Walek, D.L. Burns, et al. (1992) Myocardial infarction caused by cardiac microvasculopathy in a patient with the primary antiphospholipid synrrome. Ann. Intern. Med. 116 974-976.
201. A. Hamsten, R. Norberg, M. Björkholm, U. de Faire and G. Holm (1986) Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet 1 113-116.
202. K.E. Morton, T.P. Gavaghan, S.A. Krilis, G.E. Daggard, D.W. Baron, J.B. Hickie, et al. (1986) Coronary artery bypass graft failure—an autoimmune phenomenon? Lancet 2 1353-1357.
203. R. De Caterina, A. D'Arcanio, A. Mazzone, P. Gazzetti, W. Bernini, R. Neri, et al. (1990) Prevalence of anticardiolipin antibodies in coronary artery disease. Am. J. Cardiol. 65 922-924.
204. M. Cortellaro, C. Boschetti, M. Cardillo and T. Barbui (1992) Antiphospholipid antibodies in patients with previous myocardial infarction [letter]. Lancet 339 929-930.
205. K.E. Sletnes, P. Smith, M. Abdelnoor, H. Arnesen and F. Wisloff (1992) Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet 339 451-453.
206. T. Edwards, R.D. Thomas and N.J. McHugh (1993) Anticardiolipin antibodies in ischaemic heart disease [letter]. Lancet 342 989.
207. K.V. Phadke, R.A. Phillips, D.T. Clarke, M. Jones, P. Naish and P. Carson (1993) Anticardiolipin antibodies in ischaemic heart disease: Marker or myth? Br. Heart J. 69 391-394.
208. E. Yilmaz, K. Adalet, G. Yilmaz, S. Badur, F. Erzengin, N. Koylan, et al. (1994) Importance of serum anticardiolipin antibody levels in coronary heart disease. Clin. Cardiol. 17 117-121.
209. C. Raghavan, J. Ditchfield, R.J. Taylor, M.R. Haeney and P.C. Barnes (1993) Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J. Clin. Pathol. 46 1113-1115.
210. T.P. Gavaghan, S.A. Krilis, G.E. Daggard, D.E. Baron, J.B. Hickie and C.N. Chesterman (1987) Anticardiolipin antibodies and occlusion of coronary artery bypass grafts [letter]. Lancet 2 977-978.
211. R.L. Bick (1993) The antiphospholipid-thrombosis syndromes. Fact, fiction, confusion, and controversy [editorial]. Am. J. Clin. Pathol. 100 477-480.
212. P. Klemp, R.C. Cooper, F.J. Strauss, E.R. Jordaan, J.Z. Przybojewski and N. Nel (1988) Anti-cardiolipin antibodies in ischaemic heart disease. Clin. Exp. Immunol. 74 254-257.
213. O. Vaarala, G. Alfthan, M. Jauhiainen, M. Leirisalo-Repo, K. Aho and T. Palosua (1993) Cross reaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 341 923-925.
214. O. Vaarala (1988) Antiphospholipid antibodies and myocardial infarction. Lupus 7(Suppl. 2), S132-S134.
215. K. Aho, O. Vaarala, L. Tenkanen, H. Julkunen, T. Jouhikainen, G. Alfthan, et al. (1996) Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 14 499-506.
216. F.I. Romero, O. Amengual, T. Atsumi, M.A. Khamashta, F.J. Tinahones and G.R. Hughes (1998) Arterial disease in lupus and secondary antiphospholipid syndrome: Association with anti-β2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Br. J. Rheumatol. 37 883-888.
217. G. Hayem, P. Nicaise-Roland, E. Palazzo, M. de Bandt, F. Tubach, M. Weber, et al. (2001) Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome. Lupus 10 346-351.
218. M. Khamashta and M. Petri (1996) Antiphospholipid antibodies hasten atheroma [editorial]. Lancet 348 1088.
219. E. Matsuura, K. Kobayashi, T. Yasuda and T. Koike (1998) Antiphospholipid antibodies and atherosclerosis. Lupus 7(Suppl. 2), S135-S139.
220. J.H. Kabarowski, K. Zhu, L.Q. Le, O.N. Witte and Y. Xu (2001) Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293 702-705.
221. J. George, D. Harats, B. Gilburd, Y. Levy, P. Langevitz and Y. Shoenfeld (1999) Atherosclerosis-related markers in systemic lupus erythematosus patients: The role of humoral immunity in enhanced atherogenesis. Lupus 8 220-226.
222. R. Wu, E. Svenungsson, I. Gunnarsson, B. Andersson, I. Lundberg, L. Schafer Elinder, et al. (1999) Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE. Lupus 8 142-150.
223. P. Saikku (1997) Chlamydia pneumoniae and atherosclerosis—an update. Scand. J. Infect. Dis. Suppl. 104 53-56.
224. L.A. Jackson, L.A. Campbell, R.A. Schmidt, C.C. Kuo, A.L. Cappuccio, M.J. Lee, et al. (1997) Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: Evaluation of the innocent bystander hypothesis. Am. J. Pathol. 150 1785-1790.
225. T.C. Moazed, C. Kuo, J.T. Grayston and L.A. Campbell (1997) Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175 883-890.
226. F. Blasi, F. Denti, M. Erba, R. Cosentini, R. Raccanelli, A. Rinaldi, et al. (1996) Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J. Clin. Microbiol. 34 2766-2769.
227. S. Gupta and E.W. Leatham (1997) The relation between Chlamydia pneumoniae and atherosclerosis [editorial]. Heart 77 7-8.
228. J. Juvonen, T. Juvonen, A. Laurila, H. Alakarppa, K. Lounatmaa, H.M. Surcel, et al. (1996) Immunohistochemical detection of Chlamydia pneumoniae in abdominal aortic aneurysms. Ann. N. Y. Acad. Sci. 800 236-238.
229. M.L. Wimmer, R. Sandmann-Strupp, P. Saikku and R.L. Haberl (1996) Association of chlamydial infection with cerebrovascular disease. Stroke 27 2207-2210.
230. P.J. Cook and G.Y. Lip (1996) Infectious agents and atherosclerotic vascular disease. Q. J. Med. 89 727-735.
231. L. Capron (1996) Chlamydia in coronary plaques—hidden culprit or harmless hobo? Nat. Med. 2 856-857.
232. G. Ong, B.J. Thomas, A.O. Mansfield, B.R. Davidson and D. Taylor-Robinson (1996) Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J. Clin. Pathol. 49 102-106.
233. C.C. Kuo, J.T. Grayston, L.A. Campbell, Y.A. Goo, R.W. Wissler and E.P. Benditt (1995) Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15–34 years old). Proc. Natl. Acad. Sci. U.S.A. 92 6911-6914.
234. J.M. Esdaile, M. Abrahamowicz, T. Grodzicky, Y. Li, C. Panaritis, R. du Berger, et al. (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 44 2331-2337.
235. M.J. Roman, J.E. Salmon, R. Sobel, M.D. Lockshin, L. Sammaritano, J.E. Schwartz, et al. (2001) Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am. J. Cardiol. 87 663-666.
236. M.J. Roman, J.E. Salmon, R. Sobel, M.D. Lockshin, L. Sammaritano, J.E. Schwartz, et al. (2001) Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am. J. Cardiol. 87 A11.
237. P. Rahman, I.N. Bruce, D. Hallett, et al. (1998) Contribution of traditional risk factors to coronary artery disease in patients with SLE. J. Rheumatol. 25(Suppl. 52), S73.
238. M. Petri, D. Spence, L.R. Bone and M.C. Hochberg (1992) Coronary artery disease risk factors in the Hopkins Lupus Cohort: Prevalence, patient recognition, and preventive practices. Medicine 71 291-302.
239. P. Rahman, S. Aguero, D.D. Gladman, D. Hallett and M.B. Urowitz (2000) Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus 9 672-675.
240. N.T. Ilowite, P. Samuel, E. Ginzler and M.S. Jacobson (1988) Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum. 31 859-863.
241. R.G. Lahita, E. Rivkin, I. Cavanagh and P. Romano (1993) Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association in patients with systemic lupus erythematosus. Arthritis Rheum. 36 1566-1574.
242. E.F. Borba and E. Bonfa (1997) Dyslipoproteinemias in systemic lupus erythematosus: Influence of disease activity and anticardiolipin antibodies. Lupus 6 533-539.
243. Z.S. Alekberova, T.V. Popkova, E.L. Nasonov, T.M. Reshetniak, I.N. Ozerova and N.V. Perova (1999) The lipid-protein indices of the blood cholesterol transport system in systemic lupus erythematosus. Ter. Arkh. 71 34-38.
244. W.H. Ettinger, A.P. Goldberg, D. Applebaum-Bowden and W.R. Hazzard (1987) Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am. J. Med. 83 503-508.
245. I.N. Bruce, M.B. Urowitz and D.D. Gladman (1999) The natural history of hypercholesterolaemia in systemic lupus erythematosus. J. Rheumatol. 26 2137-2143.
246. E.F. Borba, E. Bonfa, C.G. Vinagre, J.A. Ramires and R.C. Maranhao (2000) Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum. 43 1033-1040.
247. F.I. Romero, M.A. Khamashta and G.R. Hughes (2000) Lipoprotein(a) oxidation and autoantibodies: A new path in atherothrombosis. Lupus 9 206-209.
248. M. Okawa-Takatsuji, S. Aotsuka, M. Sumiya, H. Ohta, M. Kawakami and I. Sakurabayashi (1996) Clinical significance of the serum lipoprotein(a) level in patients with systemic lupus erythematosus: Its elevation during disease flare. Clin. Exp. Rheumatol. 14 531-536.
249. J. George, B. Gilburd, P. Langevitz, Y. Levy, R. Nezlin, D. Harats, et al. (1999) Beta2 glycoprotein I containing immune-complexes in lupus patients: Association with thrombocytopenia and lipoprotein (a) levels. Lupus 8 116-120.
250. J. Font, M. Ramos-Casals, R. Cervera, M. Garcia-Carrasco, A. Torras, A. Siso, et al. (2001) Cardiovascular risk factors and the long-term outcome of lupus nephritis. Q. J. Med. 94 19-26.
251. L. Bono, J.S. Cameron and J.A. Hicks (1999) The very long-term prognosis and complications of lupus nephritis and its treatment. Q. J. Med. 92 211-218.
252. W.F. Clark and L.M. Moist (1998) Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease. Lupus 7 649-653.
253. B. Luzar and D. Ferluga (2000) Role of lipids in the progression of renal disease in systemic lupus erythematosus patients. Wien. Klin. Wochenschr. 112 716-721.
254. F. Falaschi, A. Ravelli, A. Martignoni, D. Migliavacca, M. Sartori, A. Pistorio, et al. (2000) Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 43 1405-1409.
255. A.E. Harpper, N.J. Benevenga and R.M. Wohlheuter (1976) Effects of ingestion of disproportionate amounts of amino acids. Physiol. Rev. 50 428-558.
256. G.M. Rodgers and W.H. Kane (1986) Activation of endogenous Factor V by a homocysteine induced vascular endothelial cell activator. J. Clin. Invest. 77 1909-1916.
257. J.-C. Tsai, M.A. Perrella, M. Yoshizumi, C.-M. Hsieh, E. Haber, R. Schlegel, et al. (1994) Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91 6369-6373.
258. M.J. Stampfer, M.R. Malinow, W.C. Willett, et al. (1992) A prospective study of plasma homocysteine and risk of myocardial infarction in U.S. physicians. JAMA 268 877-881.
259. J. Selhub, P.F. Jacques, A.G. Bostom, R.B. D'Agostino, P.W.F. Wilson, A.J. Belanger, et al. (1995) Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N. Engl. J. Med. 332 286-291.
260. M. Petri, R. Roubenoff, G.E. Dallal, M.R. Nadeau, J. Selhub and I.H. Rosenberg (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348 1120-1124.
261. R. Fijnheer, M. Roest, F.J. Haas, P.G. De Groot and R.H. Derksen (1998) Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: A retrospective cohort study. J. Rheumatol. 25 1737-1742.
262. P.M. Ridker, C.H. Hennekens, J.E. Buring and N. Rifai (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 836-843.
263. P.R. Ames, J. Alves, A.F. Pap, P. Ramos, M.A. Khamashta and G.R. Hughes (2000) Fibrinogen in systemic lupus erythematosus: More than an acute phase reactant? J. Rheumatol. 27 1190-1195.
264. P. Rahman, D.D. Gladman and M.B. Urowitz (2000) Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use. J. Rheumatol. 27 1323-1325.
265. D.J. Nashel (1986) Is atherosclerosis a complication of long-term corticosteroid treatment? Am. J. Med. 80 925-929.
266. J. Stamler, R. Pick and L.N. Katz (1954) Effects of cortisone, hydrocortisone and corticotropin on lipemia, glycemia and atherogenesis in cholesterol-fed chicks. Circulation 10 237-246.
267. S. Bjorkerud (1974) Effect of adrenocortical hormones on the integrity of rat aortic endothelium. G. Schettler, A. Weizel (Eds) Atherosclerosis III; Proceedings of the Third International Symposium Berlin: Springer-Verlag 245-249.
268. I. Lorenzen and L.K. Hansen (1967) Effect of glucocorticoids on human vascular connective tissue. Vasc. Dis. 4 335-341.
269. S. Rosenfeld, J. Marmorston, H. Sobel and A.E. White (1960) Enhancement of experimental atherosclerosis by ACTH in the dog. Proc. Soc. Exp. Biol. Med. 103 83-86.
270. N.P. Christy (1971) Cushing's syndrome: The natural history. N.P. Christy (Eds) The Human Adrenal Cortex New York: Harper & Row 359-394.
271. I.N. Bruce, D.D. Gladman and M.B. Urowitz (1998) Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: A quality improvement study. Clin. Exp. Rheumatol. 16 435-440.
272. M. Rosenbaum, R.I. Leibel and J. Hirsch (1997) Obesity. N. Engl. J. Med. 337 396-406.
273. Methods for voluntary weight loss and control: NIH Technology Assessment Conference Panel: Consensus Development Conference Ann. Intern. Med. 119 764-770.
274. E.J. Schaefer, A.H. Lichtenstein, S. Lam on-Fava, et al. (1995) Body weight and low-density lipoprotein cholesterol changes after cosumption of a low-fat libitum diet. JAMA 274 1450-1455.
275. L. Sheppard, A.R. Kristal and L.H. Kushi (1991) Weight loss in women participating in a randomized trial of low-fat diets. Am. J. Clin. Nutr. 54 821-888.
276. A. Tremblay and B. Buemann (1995) Exercise-training, macronutrient balance and body weight control. Int. J. Obes. Relat. Metab. Disord. 19 79-86.
277. L.C. Robb-Nicholson, L. Daltroy, H. Eaton, V. Gall, E. Wright, L.H. Hartley, et al. (1989) Effects of aerobic conditioning in lupus fatigue: A pilot study. Br. J. Rheum. 28 500-505.
278. M. Petri (1996) Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis. Lupus 5(Suppl. 1), S16-S22.
279. S.M. Haffner and H. Miettinen (1997) Insulin resistance implications for Type II diabetes mellitus and coronary heart disease. Am. J. Med. 103 152-162.
280. J.J. Nolan, B. Ludvik, P. Beerdsen, M. Joyce and J. Olefsky (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with Troglitazone. N. Engl. J. Med. 331 1188-1193.
281. M.B. Katan, S.M. Grundy and W.C. Willett (1997) Should a low-fat, high-carbohydrate diet be recommended for everyone? N. Engl. J. Med. 337 561-567.
282. M. Petri, M. Turner, J. Wagner, L. Wilder and D. Goldman (1993) Dietary intervention for hypercholesterolemia in systemic lupus erythematosus [abstract]. Arthritis Rheum. 36(Suppl.), S186.
283. S. Bertolini, G.B. Bon, L.M. Campbell, M. Farnier, J. Langan, G. Mahla, et al. (1997) Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia. Atherosclerosis 130 191-197.
284. A. Dart, G. Jerums, G. Nicholson, M. d'Emden, I. Hamilton-Craig, G. Tallis, et al. (1997) A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am. J. Cardiol. 80 39-44.
285. J. Jimenez-Alonso, J.M. Osorio, F. Gutierrez-Cabello, A. Lopez de la Osa, L. Leon and J.D. Mediavilla Garcia (1999) Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves. Arch. Intern. Med. 159 1811-1821.
286. P. Rahman, D.D. Gladman, M.B. Urowitz, K. Yuen, D. Hallett and IN Bruce (1999) The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J. Rheumatol. 26 325-330.
287. L.S. Tam, D.D. Gladman, D.C. Hallett, P. Rahman and M.B. Urowitz (2000) Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J. Rheumatol. 27 2142-2145.
288. E.F. Borba and E. Bonfa (2001) Long-term beneficial effect of choloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy. J. Rheumatol. 28 780-785.
289. J.P. Baguet, F. Tremel and M. Fabre (1999) Chloroquine cardiomyopathy with conduction disorders. Heart 81 221-223.
290. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327 685-691.
291. K. Swedberg, P. Held, J. Kjekshus, K. Rasmussen, L. Ryden and H. Wedel (1992) Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enaplapril Survival Study II (CONSENSUS II). N. Engl. J. Med. 327 678-684.
292. H. Lithell (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14 203-209.
293. L. Mykkänen, J. Kuusisto, K. Pyörälä, M. Laakso and S.M. Haffner (1994) Increased risk of non-insulin dependent diabetes mellitus in elderly hypertensive subjects. J. Hypertens. 12 1425-1432.
294. F. Grodstein, M.J. Stampfer, J.E. Manson, et al. (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335 453-461.
295. G.M. Darling, J.A. Johns, P.I. McCloud and S.R. Davis (1997) Estrogen and progestin compared with simvastation for hypercholesterolemia in postmenopausal women. N. Engl. J. Med. 337 595-600.
296. C. Kawas, S. Resnick, A. Morrison, et al. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzhemier's disease: The Baltimore longitudinal study of aging. Neurology 48 1517-1521.
297. G. Wells and D.M. Herrington (1999) The Heart and Estrogen/Progestin Replacement Study: What have we learned and what questions remain? Drugs Aging 15 419-422.
298. E. Daly, M.P. Vessey, M.M. Hawkins, J.L. Carson, P. Gough and S. Marsh (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348 977-980.
299. J. Sanchez-Guerrero, M.H. Liang, E.W. Karlson, D.J. Hunter and G.A. Colditz (1995) Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann. Intern. Med. 122 430-433.
300. G.A. Colditz, S.E. Hankinson, D.J. Hunter, et al. (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332 1589-1593.
301. J.E. Compston (1997) Designer oestrogens: Fact or fantasy? Lancet 350 676-677.
302. H. Hammerman, R.A. Kloner, S. Hale, F.J. Schoen and E. Braunwald (1983) Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 68 446-452.
303. M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt and G.R.V. Hughes (1995) The management of thrombosis in the antiphospholipid antibody syndrome. N. Engl. J. Med. 332 993-997.
304. D. Erkan, J.T. Merrill, Y. Yazici, L. Sammaritano, J.P. Buyon and M.D. Lockshin (2001) High thrombosis rate after fetal loss in antiphospholipid syndrome: Effective prophylaxis with aspirin. Arthritis Rheum. 44 1466-1467.
305. P.L. Meroni, E. Raschi, M. Camera, C. Testoni, M.A. Khamashta and E. Tremoli (2000) Fluvastatin inhibits the activation of endothelial cells induced by antiphospholipid antibodies in vitro [abstract]. Arthritis Rheum. 43(Suppl. 9), S115.
306. J.D. Laman, B.J.G.L. de Smet, A. Schoneveld and M. van Meurs (1997) CD40-CD40L interactions in atherosclerosis. Immunol. Today 18 272-277.
307. K.C. Kalunian, J. Davis, J.T. Merrill, M. Petri, J. Buyon, E. Ginzler, et al. (2000) Treatment of systemic lupus erythematosus by inhibition of T cell costimulation [abstract]. Arthritis Rheum. 43(Suppl. 9), S271.
308. S. Rosner, E.M. Ginzler, H.S. Diamond, M. Weiner, M. Schlesinger, J.E. Fries, et al. (1982) A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum. 25 612-617.
309. J. Karsh, J.H. Klippel, J.E. Balow and J.L. Decker (1979) Mortality in lupus nephritis. Arthritis Rheum. 22 764-769.
310. M.M. Ward, E. Pyun and S. Studenski (1995) Causes of death in systemic lupus erythematosus. Arthritis Rheum. 38 1492-1499.
311. J.S. Reveille, A. Bartolucci and G.S. Alarcón (1990) Prognosis in systemic lupus erythematosus: Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 33 37-48.
312. D.J. Wallace, T. Podell, J. Weiner, J.R. Klinenberg, S. Forouzesh and E.L. Dubois (1981) Systemic lupus erythematosus—survival patterns: Experience with 609 patients. J. Am. Med. Assoc. 245 934-938.
313. T. Helve (1985) Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand. J. Rheumatol. 14 43-46.
314. H. Moro, J. Hayashi, H. Okazaki, Y. Takahashi, S. Eguchi, M. Yazawa, et al. (1996) Open heart surgery in patients with systemic diseases requiring steroid treatment. Nippon Kyobu Geka Gakkai Zasshi 44 493-498.
315. H. Moro, J. Hayashi, H. Ohzeki, M. Sogawa, T. Nakayama and O. Namura (1999) Surgical management of cardiovascular lesions caused by systemic inflammatory diseases. Thorac. Cardiovasc. Surg. 47 106-110.
316. R. Grigor, J. Edmonds, R. Lewkonia, B. Bresnihan and G.R. Hughes (1978) Systemic lupus erythematosus. A prospective analysis. Ann. Rheum Dis. 37 121-128.
317. H.K. Koh, D.H. Yoo, T.S. Yoo, J.B. Jun, S.S. Jung, J.U. Lee, et al. (1998) Coexistence of coronary aneurysms and total occlusion of coronary arteries in systemic lupus erythematosus. Clin. Exp. Rheumatol. 16 739-742.
318. M.R. Dhond, A. Matayoshi and L. Laslett (1999) Coronary artery aneurysms associated with systemic lupus. Clin. Cardiol. 22 373.
319. A.H. Matayoshi, M.R. Dhond and L.J. Laslett (1999) Multiple coronary aneurysms in a case of systemic lupus erythematosus. Chest 116 1116-1118.